AMD/RETINA

Retinal biomarkers may help detect early Alzheimer disease

Mar 26, 2021

Functional and structural changes of retina measured by multifocal electroretinogram and swept-source optical coherence tomography suggest retinal biomarkers may be a useful tool in the early detection of in vivo Alzheimer disease (AD) pathologic abnormalities in cognitively normal older adults, according to a study.

In this cross-sectional study, 49 cognitively normal (CN) participants underwent an ophthalmic examination, including swept-source optical…

View Conference Coverage

Take a look at some of our conference coverage, visit our roundup section.

Videos

Jan 22, 2020
Implantable Miniature Telescope for Advanced AMD
Jan 22, 2020
Treating AMD Patients with New Technology
Jan 22, 2020
How do you Verify That a Patient Has AMD?
Jan 22, 2020
Age-related Drusen or Pathologic Drusen?
Jan 22, 2020
What is DME?
Jan 22, 2020
ENTV DME Treatment Strategy

View All

Conference Roundup

Dec 17, 2020

Most patients starting brolucizumab switch from prior anti-VEGF therapy

Approximately 94% of patients initiating treatment with brolucizumab for wet AMD switched from a different anti-VEGF treatment, according to data presented at AAO 2020 Virtual.

Using patients…